Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Esophagus (All Stages^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 4.6 (4.5, 4.6) N/A 18,157 stable stable trend -0.2 (-0.6, 0.1)
Maine 6 6.8 (6.3, 7.3) 1 (1, 3) 137 stable stable trend 0.0 (-0.8, 0.7)
New Hampshire 6 6.6 (6.1, 7.2) 2 (1, 4) 126 falling falling trend -1.1 (-1.8, -0.3)
West Virginia 6 5.8 (5.4, 6.2) 3 (2, 15) 153 stable stable trend 0.5 (-0.3, 1.3)
Iowa 7 5.7 (5.4, 6.1) 4 (2, 14) 233 stable stable trend 0.5 (-0.2, 1.1)
Ohio 6 5.6 (5.4, 5.8) 5 (3, 12) 853 rising rising trend 2.4 (1.0, 3.9)
Vermont 6 5.5 (4.9, 6.3) 6 (2, 33) 51 stable stable trend 0.2 (-1.2, 1.7)
Indiana 6 5.5 (5.2, 5.7) 7 (3, 17) 447 stable stable trend 0.0 (-0.8, 0.8)
Alaska 6 5.4 (4.7, 6.3) 8 (1, 38) 40 stable stable trend -0.4 (-2.3, 1.6)
Kentucky 7 5.4 (5.1, 5.7) 9 (3, 19) 303 stable stable trend 4.2 (-0.6, 9.3)
Michigan 6 5.4 (5.2, 5.6) 10 (4, 17) 707 falling falling trend -0.5 (-0.9, -0.2)
Pennsylvania 6 5.3 (5.2, 5.5) 11 (5, 17) 942 stable stable trend -0.3 (-0.6, 0.1)
Wisconsin 6 5.3 (5.1, 5.6) 12 (4, 19) 401 falling falling trend -0.7 (-1.3, -0.1)
Massachusetts 7 5.3 (5.1, 5.5) 13 (4, 19) 466 falling falling trend -1.9 (-2.5, -1.2)
Missouri 6 5.1 (4.9, 5.4) 14 (7, 24) 403 stable stable trend -0.3 (-0.6, 0.0)
South Dakota 6 5.1 (4.5, 5.7) 15 (3, 40) 56 stable stable trend -0.2 (-1.6, 1.2)
Rhode Island 6 5.0 (4.5, 5.6) 16 (3, 39) 71 stable stable trend 6.4 (-1.4, 14.9)
North Dakota 6 5.0 (4.3, 5.7) 17 (3, 44) 43 stable stable trend 0.2 (-1.3, 1.6)
Oregon 6 4.9 (4.6, 5.2) 18 (10, 32) 266 falling falling trend -0.9 (-1.5, -0.2)
Minnesota 6 4.9 (4.7, 5.2) 19 (12, 31) 339 stable stable trend -0.3 (-0.9, 0.2)
Washington 1 4.9 (4.7, 5.1) 20 (13, 31) 433 stable stable trend -0.5 (-1.1, 0.2)
Idaho 7 4.9 (4.4, 5.3) 21 (6, 39) 100 stable stable trend 0.0 (-0.8, 0.8)
Montana 6 4.9 (4.4, 5.4) 22 (4, 42) 70 stable stable trend 0.1 (-1.3, 1.5)
Nebraska 6 4.9 (4.5, 5.3) 23 (7, 39) 113 stable stable trend 0.1 (-0.8, 1.0)
Tennessee 6 4.8 (4.6, 5.0) 24 (14, 33) 412 stable stable trend 0.5 (0.0, 1.0)
Kansas 6 4.8 (4.4, 5.1) 25 (12, 39) 167 rising rising trend 1.3 (0.6, 2.0)
Delaware 6 4.7 (4.2, 5.3) 26 (5, 44) 62 falling falling trend -1.9 (-3.4, -0.5)
Illinois 7 4.7 (4.6, 4.9) 27 (17, 33) 740 falling falling trend -1.1 (-1.4, -0.8)
Mississippi 6 4.7 (4.4, 5.0) 28 (14, 39) 175
*
*
Connecticut 7 4.7 (4.4, 5.0) 29 (14, 38) 225 falling falling trend -1.6 (-2.4, -0.7)
Oklahoma 6 4.6 (4.4, 4.9) 30 (15, 39) 221 stable stable trend 0.1 (-0.6, 0.8)
Florida 6 4.6 (4.5, 4.7) 31 (24, 36) 1,417 falling falling trend -0.6 (-1.0, -0.3)
Alabama 6 4.5 (4.3, 4.8) 32 (20, 41) 286 falling falling trend -0.6 (-1.0, -0.2)
South Carolina 6 4.5 (4.2, 4.7) 33 (22, 42) 299 falling falling trend -1.8 (-2.4, -1.3)
New York 7 4.4 (4.3, 4.5) 34 (28, 39) 1,100 falling falling trend -1.5 (-2.1, -1.0)
Arkansas 6 4.4 (4.1, 4.7) 35 (20, 44) 173 rising rising trend 1.1 (0.3, 2.0)
Louisiana 7 4.4 (4.2, 4.7) 36 (23, 43) 250 falling falling trend -0.9 (-1.3, -0.4)
Georgia 7 4.4 (4.2, 4.5) 37 (28, 42) 512 falling falling trend -1.2 (-1.6, -0.8)
Maryland 6 4.3 (4.1, 4.5) 38 (28, 44) 314 falling falling trend -1.7 (-2.3, -1.1)
New Jersey 7 4.3 (4.1, 4.5) 39 (30, 44) 488 falling falling trend -1.2 (-1.5, -0.9)
North Carolina 6 4.2 (4.0, 4.3) 40 (34, 45) 534 falling falling trend -1.0 (-1.5, -0.6)
Virginia 6 4.1 (3.9, 4.3) 41 (35, 47) 422 falling falling trend -1.4 (-1.8, -1.0)
Colorado 6 4.1 (3.8, 4.3) 42 (35, 47) 255 stable stable trend -0.7 (-1.4, 0.1)
Arizona 6 4.0 (3.9, 4.2) 43 (37, 47) 366 falling falling trend -0.7 (-1.3, -0.1)
Texas 7 4.0 (3.8, 4.1) 44 (40, 47) 1,141 stable stable trend -0.2 (-1.1, 0.7)
Wyoming 6 3.9 (3.2, 4.6) 45 (19, 50) 28 falling falling trend -2.7 (-4.7, -0.6)
New Mexico 7 3.7 (3.4, 4.1) 46 (38, 49) 102 stable stable trend 0.0 (-0.7, 0.7)
Hawaii 7 3.6 (3.2, 4.0) 47 (40, 50) 69 stable stable trend -0.2 (-0.9, 0.5)
District of Columbia 6 3.6 (3.0, 4.3) 48 (28, 50) 24 falling falling trend -5.3 (-6.8, -3.7)
California 7 3.5 (3.4, 3.6) 49 (46, 50) 1,538 falling falling trend -1.1 (-1.4, -0.8)
Utah 7 3.1 (2.8, 3.4) 50 (47, 50) 85 stable stable trend -0.5 (-1.7, 0.7)
Puerto Rico 6 2.8 (2.6, 3.0) N/A 123 stable stable trend -2.5 (-8.6, 3.9)
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 06/02/2023 12:28 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).
7 Source: SEER November 2021 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2021 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top